Skip to content
Beacon

PILLDirexion Daily Pharmaceutical & Medical Bull 3X Shares ETF

Take a bet8y track recordRanked #334 of 775 in this goal

Seeks daily investment results of 300% of the daily performance of the Index.

By Direxion Funds · Launched 2017

Annual Cost

0.98%

#4,853 of 5,562 · expensive

Fund Size

$14M

#4,603 of 5,562 · small

Return (1Y)Goal

+169.1%

Track Record

8 years

#1,669 of 5,562 · established

Performance

Total-return NAV · USD
Growth of $10,000
$26,705+167.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Leveraged

Sector

Health care

Index tracked

S&P Pharmaceuticals & Medical Equipment & Devices Select Industry Index

What it actually holds

By weight

Concentration

Top 10 holdings = 72.4% of fundconcentrated

N/A
18.4%
DREYFUS GOVERNMENT CASH MANAGE
11.5%
GOLDMAN FINANCIAL
11.3%
N/A
10.4%
GOLDMAN SACHS LIQ ES FD A
10.4%
Tarsus Pharmaceuticals Inc
2.2%
Crinetics Pharmaceuticals Inc.
2.1%
Elanco Animal Health Inc
2.1%
Supernus Pharmaceuticals, Inc
2.1%
Ligand Pharmaceuticals Incorporated
2.0%

Asset allocation

Stocks
74.5%
Cash
25.4%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
62.3%High

Year-on-year price swings

Max drawdown
-88.8%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.55Decent risk-adjusted returns
Sortino (3Y)
0.79Moderate downside risk

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks daily investment results of 300% of the daily performance of the Index.
Strategy
Invests primarily in financial instruments like swap agreements and ETFs to achieve 3X daily leveraged exposure to pharmaceutical and medical stocks in the S&P Total Market Index. The Fund rebalances daily to maintain its target exposure, which may lead to high portfolio turnover.
Inception date
November 15, 2017
Fund family
Direxion Funds

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged
Warning

Leveraged ETF — not a long-term hold

This fund uses leverage to amplify daily returns (e.g. 2x or 3x of an index). Daily rebalancing creates volatility decay — over weeks and months, the fund's return drifts from the stated multiple. In trending markets with low realised volatility, leveraged index ETFs can outperform their nominal multiple; in sideways or volatile markets they bleed. Designed for short-term tactical use, not buy-and-hold.

Source: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)

Why we flagged this: strategy=leveraged + leveraged_name_or_strategy

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed PILL. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19